https://community.qualistery.com/question/pqs-and-qms/ 2021-07-21T11:52:44+00:00 monthly 0.6 https://community.qualistery.com/question/tablet-hardness/ 2021-07-22T08:51:44+00:00 monthly 0.6 https://community.qualistery.com/question/silicone-oil-for-siliconised-prefilled-syringes-testing/ 2021-07-22T09:36:30+00:00 monthly 0.6 https://community.qualistery.com/question/supplier-qualifications/ 2021-07-22T17:18:11+00:00 monthly 0.6 https://community.qualistery.com/question/is-contact-lens-solution-classified-as-a-medical-device-and-therefore-subject-to-gxp/ 2021-07-26T19:15:39+00:00 monthly 0.6 https://community.qualistery.com/question/how-often-should-you-perform-a-product-quality-review-pqr/ 2021-08-02T06:55:12+00:00 monthly 0.6 https://community.qualistery.com/question/sampling-in-the-warehouse/ 2021-08-06T08:13:30+00:00 monthly 0.6 https://community.qualistery.com/question/iso-9001-and-qms/ 2021-08-08T15:50:08+00:00 monthly 0.6 https://community.qualistery.com/question/gxp-requirements-for-cold-chain-monitoring/ 2021-08-09T06:45:45+00:00 monthly 0.6 https://community.qualistery.com/question/cgmp-regulations-permit-the-destruction-of-an-internal-quality/ 2021-08-10T16:43:23+00:00 monthly 0.6 https://community.qualistery.com/question/cleaning-validation/ 2021-08-11T05:29:52+00:00 monthly 0.6 https://community.qualistery.com/question/who-is-responsible-for-analytically-testing-apis/ 2021-08-10T15:53:03+00:00 monthly 0.6 https://community.qualistery.com/question/must-each-batch-of-a-united-states-pharmacopeia-usp-grade-api-be-tested-using-the-analytical-procedures-specified-in-the-usp-monograph/ 2021-08-12T03:03:56+00:00 monthly 0.6 https://community.qualistery.com/question/document-retention/ 2021-08-12T10:29:04+00:00 monthly 0.6 https://community.qualistery.com/question/are-hbels-health-based-exposure-limits-required-for-all-medicinal-products/ 2021-08-13T14:40:04+00:00 monthly 0.6 https://community.qualistery.com/question/are-there-any-special-processing-or-handling-concerns-for-flexible-intravenous-iv-solution-bags/ 2021-08-14T19:17:49+00:00 monthly 0.6 https://community.qualistery.com/question/is-there-any-method-that-could-be-used-to-define-the-significance-of-the-health-based-exposure-limit-hbel-such-that-there-can-be-broad-guidance-on-the-extent-of-quality-risk-management-qrm-and-con/ 2021-08-16T10:47:40+00:00 monthly 0.6 https://community.qualistery.com/question/what-should-drug-manufacturers-do-to-prevent-formation-of-glass-lamellae-glass-fragments-in-injectable-drugs-filled-in-small-volume-glass-vials/ 2021-08-20T14:05:37+00:00 monthly 0.6 https://community.qualistery.com/question/how-do-you-perform-a-lean-but-also-sufficient-capa-effectiveness-check/ 2021-08-23T10:58:57+00:00 monthly 0.6 https://community.qualistery.com/question/are-there-control-measures-for-minimizing-pathogenic-agent-contamination-in-animal-derived-drug-ingredient-manufacturing-facilities/ 2021-09-04T05:31:51+00:00 monthly 0.6 https://community.qualistery.com/question/what-are-some-ways-to-minimize-pathogenic-agent-contamination-in-incoming-animal-derived-raw-material/ 2021-09-04T05:33:59+00:00 monthly 0.6 https://community.qualistery.com/question/how-should-manufacturers-use-the-hbels-health-based-exposure-limits/ 2021-09-04T05:35:35+00:00 monthly 0.6 https://community.qualistery.com/question/what-methods-of-analysis-are-suitable-for-testing-for-melamine-contamination-in-pharmaceutical-components/ 2021-09-04T05:35:29+00:00 monthly 0.6 https://community.qualistery.com/question/what-manufacturing-contamination-risks-are-presented-by-the-different-pathogenic-agents/ 2021-09-04T05:36:48+00:00 monthly 0.6 https://community.qualistery.com/question/what-skills-are-required-for-the-person-developing-the-health-based-exposure-limits-hbel/ 2021-09-04T05:48:58+00:00 monthly 0.6 https://community.qualistery.com/question/what-are-fdas-primary-concerns-about-pathogenic-agent-contamination-of-animal-derived-drug-ingredients/ 2021-09-04T05:48:49+00:00 monthly 0.6 https://community.qualistery.com/question/does-fda-require-or-recommend-any-special-precautions-or-controls-over-the-manufacturing-of-animal-derived-drug-ingredients-to-prevent-contamination/ 2021-09-04T05:48:43+00:00 monthly 0.6 https://community.qualistery.com/question/what-responsibility-do-contract-givers-have-to-contract-manufacturers-in-relation-to-data-to-support-a-hbel-assessment/ 2021-09-04T05:48:30+00:00 monthly 0.6 https://community.qualistery.com/question/is-analytical-testing-required-at-product-changeover-on-equipment-in-shared-facilities-following-completion-of-cleaning-validation/ 2021-09-04T05:48:20+00:00 monthly 0.6 https://community.qualistery.com/question/what-are-the-specs-and-requirements-for-conducting-visual-inspection-as-per-qa-7/ 2021-09-04T05:48:07+00:00 monthly 0.6 https://community.qualistery.com/question/is-it-acceptable-to-simply-segregate-products-of-a-common-therapeutic-classification/ 2021-09-04T05:48:02+00:00 monthly 0.6 https://community.qualistery.com/question/how-many-containers-of-each-component-from-each-shipment-must-a-firm-sample-and-test-to-comply-with-the-cgmp-requirements-for-identity-testing-do-the-cgmps-permit-the-identity-test-on-a-pooled-or-c/ 2021-09-04T05:47:53+00:00 monthly 0.6